WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Blake BorgesonDirector2026-07-0740,000$3.96
$158.48kSell
Namandje BumpusDirector2026-06-183,963$3.18
$12.60kSell
Ben R. TaylorChief Financial Officer2026-06-155,396$3.15
$17.00kSell
Christopher GibsonDirector2026-06-0540,000$3.62
$144.80kSell
Najat KhanCEO and President2026-06-0523,588$3.58
$84.47kSell
Namandje BumpusDirector2026-06-034,386$3.54
$15.53kSell
Blake BorgesonDirector2026-06-0230,000$3.68
$110.40kSell
Christopher GibsonDirector2026-05-2240,000$3.08
$123.20kSell
Christopher GibsonDirector2026-05-1522,821$3.04
$69.38kSell
Ben R. TaylorChief Financial Officer2026-05-1525,018$3.04
$76.05kSell

1 of 7

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc8.15%43,192,306$153.76MInstitution
Ark Investment Management LLC7.59%40,212,769$143.16MInstitution
Lux Ventures IV LP5.72%30,308,614$107.90MInsider
State Street Corp5.38%28,490,638$101.43MInstitution
Baillie Gifford Co4.47%23,675,407$84.28MInstitution
Vanguard Portfolio Management LLC4.29%22,759,100$81.02MInstitution
Vanguard Capital Management LLC4.20%22,244,387$79.19MInstitution
Softbank Group Corp2.57%13,636,515$48.55MInstitution
Geode Capital Management LLC2.32%12,275,084$43.70MInstitution
MIC Capital Management Uk LLP1.82%9,644,032$34.33MInstitution

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX63.44%13.64%Net SellingNet Selling
ZBIO74.49%25.51%Net BuyingNet Buying
DMRA77.24%22.76%Net SellingNet Selling
IOVA19.87%80.13%Net SellingNet Selling
FTRE99.13%0.87%Net SellingNet Selling
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 63.44% institutional shareholders, 13.64% Recursion Pharmaceuticals insiders, and 22.92% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 5.72% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $100.02M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.